Royal Bank Of Canada Bright Minds Biosciences Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.41 - $0.7 $136 - $232	332 Added 15.95%	2,413 $1,000
Q1 2023 May 15, 2023	BUY	$0.41 - $0.87 $89 - $189	218 Added 11.7%	2,081 $0
Q4 2022 Feb 14, 2023	BUY	$0.74 - $6.0 $198 - $1,608	268 Added 16.8%	1,863 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.75 - $6.5 $12 - $104	16 Added 1.01%	1,595 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.8 - $1.57 $1,072 - $2,103	1,340 Added 560.67%	1,579 $1,000
Q1 2022 May 16, 2022	BUY	$1.44 - $3.37 $344 - $805	239 New	239 $0

Ticker DRUG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,209,900
Market Cap $640M
Description
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collabor...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.